Ovarian cancer is a common and the most lethal type of gynecological cancer. Primary debulking surgery followed by chemotherapy is currently the standard of care for patients with advanced ovarian cancer. However, patients have differential responses to chemotherapy, predicting the prognosis of chemotherapy therefore become paramount important. Recent advances inthe use of DNA microarrays, which allow global assessment of gene expression in a single sample, have shown that expression profiles can provide mo...